Related Experiment Video

Updated: Aug 17, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Outcome analysis of patients requiring mechanical ventilation with severe community-acquired pneumonia and identified

Han-Chung Hu1, Chung-Chi Huang, Ying-Huang Tsai

  • 1Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Taipei.

Chang Gung Medical Journal
|July 15, 2005
PubMed
Abstract

Insights

Severe community-acquired pneumonia (CAP) is deadly, often caused by Gram-negative bacteria like Klebsiella pneumoniae. Treatment should target these pathogens, considering antibiotic resistance, as older age and higher APACHE II scores increase mortality risk.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Severe community-acquired pneumonia (CAP) presents a significant mortality risk.
  • Effective antibiotic selection hinges on understanding prevalent bacterial pathogens.
  • This study investigated causative agents and outcomes in severe CAP patients within a Taiwanese medical intensive care unit (MICU).

Purpose of the Study:

  • To analyze the spectrum of bacterial pathogens responsible for severe CAP.
  • To evaluate patient outcomes in relation to identified pathogens.
  • To inform empirical antibiotic treatment strategies for severe CAP.

Main Methods:

  • Inclusion of intubated patients with severe CAP requiring mechanical ventilation in an MICU.
  • Focus on patients with identified bacterial pathogens.
  • Comparison of demographic and clinical factors (age, APACHE II score, PaO2/FiO2 ratio) between survivors and non-survivors.

Main Results:

  • Klebsiella pneumoniae was the predominant pathogen (21.3%), followed by Pseudomonas aeruginosa and Acinetobacter baumannii.
  • Staphylococcus aureus was the most common Gram-positive isolate, with 50% exhibiting oxacillin resistance (ORSA).
  • Overall mortality reached 55.9%, with younger age and lower APACHE II scores correlating with survival.

Conclusions:

  • Gram-negative bacilli dominate severe CAP pathogens in mechanically ventilated patients.
  • Empirical therapy should include agents covering Pseudomonas species, ESBL-producing strains, and Acinetobacter species, alongside coverage for ORSA.
  • Advanced age and elevated APACHE II scores are critical predictors of mortality in severe CAP.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.